Noah G Weiss, 39Cypress, TX

2022040, Dec 22, 2022

Jan 31, 2022

17/589865

- San Francisco CA, US
Andrew Schmidt - San Francisco CA, US
Joseph Delgado - New York NY, US
Jonathan Katzur - San Francisco CA, US
Japinder Singh - New York NY, US
Joshua Wills - San Francisco CA, US
Simon Favreau-Lessard - New York NY, US
Noah Weiss - Austin TX, US
Luis Tandalla - Jersey City NJ, US

H04W 4/08
H04L 67/12
H04L 41/22
H04W 8/00

Embodiments of the present disclosure provide methods, systems, apparatuses, and computer program products for discovery of organizational telemetry within a group-based communication system and rendering representations thereof

2019038, Dec 26, 2019

Sep 6, 2019

16/562629

- Indianapolis IN, US
Hans-Peter Josel - Weilheim, DE
Eloisa Lopez-Calle - Ludwigshafen, DE
Josef Roedl - Mutterstadt, DE
Noah Weiss - Cypress TX, US
Benjamin Tiemann - Muenchen, DE

Roche Diagnostics Operations, Inc. - Indianapolis IN

A61K 31/436
A61K 47/18
A61K 9/08

The present description relates to a liquid composition having at least one immune-modulatory macrolide compound and an essentially cell-free blood hemolysate. The present description further relates to a method for manufacturing a stabilized immune-modulatory macrolide calibration solution, by a) preparing a solution comprising an essentially cell-free blood hemolysate, b) admixing a predetermined amount of at least one immune-modulatory macrolide into said solution comprising an essentially cell-free blood hemolysate, and, thereby c) manufacturing a stabilized immune-modulatory macrolide calibration solution. Furthermore, the present description relates to kits, uses, devices, methods and to an immune-modulatory macrolide compound calibration solution related thereto.

2019004, Feb 14, 2019

Oct 12, 2018

16/158931

- Indianapolis IN, US
Roland Thiele - Kochel, DE
Noah Weiss - Cypress TX, US
Benjamin Tiemann - Munich, DE

Roche Diagnostics Operations, Inc. - Indianapolis IN

G01N 33/68
G01N 33/58
G01N 30/72
B01D 59/44

A method and an apparatus for determining a concentration of a target analyte in a sample of bodily fluid are disclosed. The method involves providing a sample of bodily fluid including the target analyte, providing an internal standard solution including a mixture of components having a plurality of isotopes of the target analyte, wherein a concentration of each isotope is unknown, adding the internal standard solution to the sample, analyzing the sample including the internal standard solution using a mass spectrometer, creating a sample function curve based on signal intensities, wherein the signal intensities define arbitrary units, transferring an analyte signal into a corresponding arbitrary analyte unit by means of the sample function curve, and transferring the arbitrary analyte unit into the concentration of a target analyte by means of a standardization function representing a curve of concentrations depending on the arbitrary units.

2015036, Dec 17, 2015

Feb 3, 2014

14/764875

Mark HAYES - Gilbert AZ, US
Paul JONES - Mesa AZ, US
Stacy KENYON - Baltimore MD, US
Micheal KEEBAUGH - Mesa AZ, US
Thomas TAYLOR - Tempe AZ, US
Prasun MAHANTI - Tempe AZ, US
Sarah STATON - Washington DC, US
Noah WEISS - Chandler AZ, US
- Scottsdale AZ, US

ARIZONA BORAD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY - Scottsdale AZ

B03C 7/02
G06F 17/50
B01L 3/00

The present invention provides devices and methods to separate and concentrate target species. In some embodiments, a punctuated continuous microchannel or parallel processing (array-based) separations are provided, the microchannel having a plurality of sequential, constrictive insulating features to form a plurality of reservoirs including a first, second and third reservoir, and a plurality of constricted passageways including a first constricted passageway that connects the first reservoir to the second reservoir and a second constricted passageway that connects the second reservoir to the third reservoir. A voltage is applied to the microchannel to create different electrical fields and/or different dielectrophoresis (DEP) gradients at each of the plurality of constricted passageways in order to separate species that have differing ratios of electrokinetic mobility to dielectrophoretic mobility.